Related Experiment Video

Updated: Jun 12, 2026

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models
05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

Targeting GRP78 to enhance melanoma cell death

Shaun Martin1, David S Hill, James C Paton

  • 1Northern Institute of Cancer Research and Newcastle Cancer Centre, Newcastle University, Newcastle upon Tyne, UK.

Pigment Cell & Melanoma Research
|June 16, 2010
PubMed

Insights

Targeting endoplasmic reticulum stress with GRP78 inhibition enhances melanoma cell death. Combining GRP78 down-regulation with agents like fenretinide or bortezomib offers a novel therapeutic strategy for metastatic melanoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Metastatic melanoma treatment remains challenging.
  • Endoplasmic reticulum (ER) stress-induced apoptosis is a potential therapeutic target.
  • The unfolded protein response (UPR) can promote melanoma cell survival by mitigating ER stress.

Purpose of the Study:

  • To investigate if inhibiting GRP78, a key UPR mediator, enhances apoptosis in melanoma cells when combined with ER stress-inducing agents.
  • To evaluate the efficacy of combining GRP78 down-regulation with fenretinide or bortezomib.

Main Methods:

  • Small-interfering RNA (siRNA) was used to down-regulate GRP78 expression.
  • Melanoma cells were treated with fenretinide or bortezomib, with and without GRP78 inhibition.
  • A GRP78-specific subtilase toxin was employed to inhibit GRP78 function.

Main Results:

  • siRNA-mediated GRP78 down-regulation significantly increased fenretinide- or bortezomib-induced apoptosis.
  • Treatment with a GRP78-specific subtilase toxin synergistically enhanced the apoptotic effects of fenretinide and bortezomib.
  • These findings demonstrate that targeting GRP78 potentiates ER stress-induced cell death.

Conclusions:

  • Inhibiting GRP78, a crucial UPR component, sensitizes melanoma cells to ER stress-inducing apoptosis.
  • Combination strategies involving ER stress inducers and GRP78 down-regulation present a promising novel therapeutic approach for metastatic melanoma.
  • Targeting the UPR pathway offers a new avenue for overcoming therapeutic resistance in melanoma.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...